相关实验视频
Updated: Jun 28, 2025
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.5K
药物基因组学辅助的精神分裂症管理:一种混合型2有效性-实施研究方案,用于比较临床效用,成本效益和障碍
Aniruddha Basu1, Atanu Kumar Dutta2, Bhavani Shankara Bagepally3
1Department of Psychiatry, All India Institute of Medical Sciences, Kalyani, India.
PloS one
|April 10, 2024
概括
药物遗传学 (PGx) 测试可以个性化精神分裂症的抗精神病治疗,提高安全性和有效性. 这项研究评估了PGx辅助护理的价值.
科学领域:
- 精神病学和药理学 精神病学和药理学
- 遗传学和精准医学 遗传学和精准医学
背景情况:
- 对抗精神病治疗的反应在个体之间有很大差异.
- 药物遗传学 (PGx) 因素影响抗精神病药物的有效性和安全性.
- 精神分裂症的管理需要个性化的治疗方法.
研究的目的:
- 评估PGx辅助抗精神病药物管理与精神分裂症患者标准护理的临床效用,成本效益和实施因素.
- 评估PGx引导治疗选择的安全性和有效性.
- 确定在印度东部的三级医院环境中实施PGx辅助护理的促进者和障碍.
主要方法:
- 一种混合型2的有效性-实施研究设计.
- 第1部分:随机对照试验比较PGx辅助治疗 (基于DRD2,HTR1A,HTR2C,ABCB1,CYP2D6,CYP3A5,CYP1A2中的SNP) 与12周的标准护理.
- 第二部分:成本效益分析. 第三部分:对实施促进因素和障碍物的定性探索.
主要成果:
- 主要终点:Udvalg for Kliniske Undersøgelser副作用评分表分数组之间的差异.
- 将对血清药物水平进行监测.
- 研究结果将为PGx辅助精神分裂症管理的临床实用性和成本效益提供信息.
结论:
- 这项研究旨在确定PGx辅助管理是否为精神分裂症提供临床效用和成本效益.
- 了解实施方便者和障碍者对于成功融入临床实践至关重要.
- 结果将指导个性化抗精神病治疗在不同的医疗机构.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
124
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
124
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:12Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
01:28Psychosis and Antipsychotic Drugs: Overview
246
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
246
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
134
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
134